Pediatrics Doctors in College Park, GA Accepting Medicare

5 Pediatrics doctors found. Showing 1 - 5

Dr. Roslyn Payne-pamphile, M.D Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 5495 Old National Hwy Ste B2, College Park, GA 30349 Phone: 404-559-8847    Fax: 404-559-8998

Mrs. Jamika Warren Trawick, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2565 Jolly Rd, Suite A, College Park, GA 30349 Phone: 404-765-9437    Fax: 404-669-9347

Gertrude Brown Arrington, MD Pediatrics Medicare: Not Enrolled in Medicare Practice Location: 1720 Phoenix Blvd, College Park, GA 30349 Phone: 770-909-8007    Fax: 770-909-8005

Brittany Renee Cole, MD Pediatrics Medicare: Medicare Enrolled Practice Location: 2565 Jolly Rd Ste A, College Park, GA 30349 Phone: 404-765-9437    Fax: 770-964-9021

Dr. Helena K Bentley, M.D. Pediatrics Medicare: Medicare Enrolled Practice Location: 2565 Jolly Rd Ste A, College Park, GA 30349 Phone: 404-765-9437    Fax: 770-964-9021

News Archive

Discovery could prolong life of people living with glioblastoma

Researchers at the University of Calgary's Hotchkiss Brain Institute and Southern Alberta Cancer Research Institute have made a discovery that could prolong the life of people living with glioblastoma – the most aggressive type of brain cancer. Samuel Weiss, PhD, Professor and Director of the HBI, and Research Assistant Professor Artee Luchman, PhD, and colleagues, published their work today in Clinical Cancer Research, which is leading researchers to start a human phase I/II clinical trial as early as Spring 2015.

Panacea Global announces name change

Panacea Global Inc.,, a biopharmaceutical company specializing in blood (protein), serum and tissue tests to diagnose and monitor cancer, today announced the change of the Company's official trading symbol from MLXG to PANG.

The Transcatheter Cardiovascular Therapeutics 2009 to feature PLCs' RenalGuard System

PLC Systems Inc. (OTC Bulletin Board: PLCSF), a company focused on innovative cardiac and vascular medical device-based technologies, today announced that it will demonstrate its RenalGuard System(TM) at Transcatheter Cardiovascular Therapeutics (TCT) 2009, sponsored by the Cardiovascular Research Foundation, September 21 - 25, 2009, in San Francisco, California. More than 11,000 clinicians and professionals are expected to attend this event.

New FAU study examines extent of ‘self-cyberbullying' behavior among teens

Adolescents harming themselves with cuts, scratches or burns has gained a lot of attention over the years not just because of the physical damage and internal turmoil, but also because it has been linked to suicide. More recently, a new form of self-harm in youth has emerged and is cause for concern, warns a researcher and bullying expert from Florida Atlantic University.

Catalyst Pharmaceutical Partners, NIDA to jointly conduct Phase II(b) trial of CPP-109 for cocaine addiction

Catalyst Pharmaceutical Partners, Inc. announced today that it has signed a definitive Clinical Trial Agreement (CTA) with the National Institute on Drug Abuse (NIDA) to jointly conduct a U.S. Phase II(b) clinical trial evaluating CPP-109, Catalyst's formulation of vigabatrin, for the treatment of cocaine addiction. As part of the CTA, NIDA, under their agreement with Veteran's Administration Cooperative Studies Program, will provide substantial resources for the estimated $10 million trial cost.

Read more Medical News

› Verified 3 days ago